TP53 and metastatic colorectal cancer: Here, we obtained data from metastatic colorectal cancer patients undergoing molecular testing by targeted gene sequencing, and we identified SMAD4 and FBXW7 mutated genes as negative prognostic markers in TP53–driven tumors, which also improved the predictive performance to discriminate high–risk patients beyond clinical factors alone.